🇺🇸 Human Recombinant Regular Insulin infusion in United States

Human Recombinant Regular Insulin infusion (Human Recombinant Regular Insulin infusion) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Human Recombinant Regular Insulin infusion in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Human Recombinant Regular Insulin infusion approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Human Recombinant Regular Insulin infusion in United States?

Wanpen Vongpatanasin is the originator. The local marketing authorisation holder may differ — check the official source linked above.